Progressive Care, Inc. (RXMD)
- Previous Close
1.8000 - Open
1.7600 - Bid --
- Ask --
- Day's Range
1.7600 - 1.7600 - 52 Week Range
0.4000 - 6.0500 - Volume
102 - Avg. Volume
2,627 - Market Cap (intraday)
10.984M - Beta (5Y Monthly) -0.25
- PE Ratio (TTM)
-- - EPS (TTM)
-2.6100 - Earnings Date May 10, 2024 - May 14, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Progressive Care, Inc. operates as a healthcare services and technology company in south Florida. The company provides prescription pharmaceuticals; COVID-19 related diagnostics and vaccinations; compounded medications; tele-pharmacy services; anti-retroviral medications; medication therapy management; and medication adherence packaging and contracted pharmacy services. It also supplies various prescription medications to long term care facilities. In addition, the company offers computerized maintenance of patient prescription histories; third party billing; and consultant pharmacist services consisting of evaluation of monthly patient drug therapy and monitoring the institution's drug distribution system, as well as data management and reporting services to support health care organizations. Progressive Care, Inc. is based in Hallandale Beach, Florida. Progressive Care, Inc. operates as a subsidiary of NextPlat Corp.
progressivecareus.com143
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: RXMD
Performance Overview: RXMD
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RXMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RXMD
Valuation Measures
Market Cap
10.98M
Enterprise Value
4.75M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.14
Price/Book (mrq)
0.41
Enterprise Value/Revenue
0.11
Enterprise Value/EBITDA
-0.63
Financial Highlights
Profitability and Income Statement
Profit Margin
-39.04%
Return on Assets (ttm)
-0.26%
Return on Equity (ttm)
-113.60%
Revenue (ttm)
49.73M
Net Income Avi to Common (ttm)
-14.65M
Diluted EPS (ttm)
-2.6100
Balance Sheet and Cash Flow
Total Cash (mrq)
7.89M
Total Debt/Equity (mrq)
6.26%
Levered Free Cash Flow (ttm)
-748.12k
Company Insights: RXMD
RXMD does not have Company Insights